Читать книгу Sarcopenia - Группа авторов - Страница 43

1 1. Dodds, R.M., et al., Global variation in grip strength: a systematic review and meta‐analysis of normative data. Age and Ageing, 2016. 45(2): p. 209–216.

2 2. Moore, A.Z., et al., Difference in muscle quality over the adult life span and biological correlates in the Baltimore Longitudinal Study of Aging. Journal of the American Geriatrics Society, 2014. 62(2): p. 230–236.

3 3. Walker, J.B., Creatine: biosynthesis, regulation, and function. Advances in Enzymology and Related Areas of Molecular Biology, 1979. 50: p. 177–242.

4 4. Barclay, C., Energy demand and supply in human skeletal muscle. Journal of Muscle Research and Cell Motility, 2017. 38(2): p. 143–155.

5 5. Kemp, G.J., M. Meyerspeer, and E. Moser, Absolute quantification of phosphorus metabolite concentrations in human muscle in vivo; by 31P MRS: a quantitative review. NMR in Biomedicine: An International Journal Devoted to the Development and Application of Magnetic Resonance in vivo, 2007. 20(6): p. 555–565.

6 6. Lanza, I.R., D.E. Befroy, and J.A. Kent‐Braun, Age‐related changes in ATP‐producing pathways in human skeletal muscle in vivo. Journal of Applied Physiology, 2005. 99(5): p. 1736–1744.

7 7. Schocke, M.F., et al., High‐energy phosphate metabolism during incremental calf exercise in humans measured by 31 phosphorus magnetic resonance spectroscopy (31P MRS). Magnetic Resonance Imaging, 2004. 22(1): p. 109–115.

8 8. Rygiel, K.A., M. Picard, and D.M. Turnbull, The ageing neuromuscular system and sarcopenia: a mitochondrial perspective. The Journal of Physiology, 2016. 594(16): p. 4499–4512.

9 9. Wallace, D.C., Mitochondrial genetic medicine. Nature Genetics, 2018. 50(12): p. 1642–1649.

10 10. Migliavacca, E., et al., Mitochondrial oxidative capacity and NAD+ biosynthesis are reduced in human sarcopenia across ethnicities. Nature Communications, 2019. 10(1): p. 1–14.

11 11. Coen, P.M., et al., Mitochondria as a target for mitigating sarcopenia. Frontiers in Physiology, 2019. 9: p. 1883.

12 12. Menshikova, E.V., et al., Calorie restriction‐induced weight loss and exercise have differential effects on skeletal muscle mitochondria despite similar effects on insulin sensitivity. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 2017. 73(1): p. 81–87.

13 13. Menshikova, E.V., et al., Effects of exercise on mitochondrial content and function in aging human skeletal muscle. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 2006. 61(6): p. 534–540.

14 14. Distefano, G. and B.H. Goodpaster, Effects of exercise and aging on skeletal muscle. Cold Spring Harbor Perspectives in Medicine, 2018. 8(3): a029785. doi:10.1101/cshperspect.a029785.

15 15. Distefano, G., et al., Chronological age does not influence ex‐vivo mitochondrial respiration and quality control in skeletal muscle. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 2017. 72(4): p. 535–542.

16 16. Trounce, I., E. Byrne, and S. Marzuki, Decline in skeletal muscle mitochondrial respiratory chain function: possible factor in ageing. The Lancet, 1989. 333(8639): p. 637–639.

17 17. Boffoli, D., et al., Decline with age of the respiratory chain activity in human skeletal muscle. Biochimica et Biophysica Acta (BBA) ‐ Molecular Basis of Disease, 1994. 1226(1): p. 73–82.

18 18. Tonkonogi, M., et al., Reduced oxidative power but unchanged antioxidative capacity in skeletal muscle from aged humans. Pflügers Archiv, 2003. 446(2): p. 261–269.

19 19. Short, K.R., et al., Decline in skeletal muscle mitochondrial function with aging in humans. Proceedings of the National Academy of Sciences, 2005. 102(15): p. 5618–5623.

20 20. Lanza, I.R. and K.S. Nair, Muscle mitochondrial changes with aging and exercise. The American Journal of Clinical Nutrition, 2009. 89(1): p. 467S–471S.

21 21. Porter, C., et al., Mitochondrial respiratory capacity and coupling control decline with age in human skeletal muscle. American Journal of Physiology. Endocrinology and Metabolism, 2015. 309(3): p. E224–E232.

22 22. Kauppila, T.E., J.H. Kauppila, and N.‐G. Larsson, Mammalian mitochondria and aging: an update. Cell Metabolism, 2017. 25(1): p. 57–71.

23 23. Gonzalez‐Freire, M., et al., Skeletal muscle ex vivo; mitochondrial respiration parallels decline in vivo; oxidative capacity, cardiorespiratory fitness, and muscle strength: the Baltimore Longitudinal Study of Aging. Aging Cell, 2018. 17(2): p. e12725.

24 24. Ubaida‐Mohien, C., et al., Discovery proteomics in aging human skeletal muscle finds change in spliceosome, immunity, proteostasis and mitochondria. Elife, 2019. 8: e49874. doi:10.7554/eLife.49874.

25 25. Choi, S., et al., 31P magnetic resonance spectroscopy assessment of muscle bioenergetics as a predictor of gait speed in the Baltimore Longitudinal Study of Aging. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 2016. 71(12): p. 1638–1645.

26 26. Coen, P.M., et al., Skeletal muscle mitochondrial energetics are associated with maximal aerobic capacity and walking speed in older adults. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 2013. 68(4): p. 447–455.

27 27. Zane, A.C., et al., Muscle strength mediates the relationship between mitochondrial energetics and walking performance. Aging Cell, 2017. 16(3): p. 461–468.

28 28. Santanasto, A.J., et al., Skeletal muscle mitochondrial function and fatigability in older adults. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 2015. 70(11): p. 1379–1385.

29 29. Joseph, A.M., et al., The impact of aging on mitochondrial function and biogenesis pathways in skeletal muscle of sedentary high‐and low‐functioning elderly individuals. Aging Cell, 2012. 11(5): p. 801–809.

30 30. Gouspillou, G., et al., Mitochondrial energetics is impaired in vivo; in aged skeletal muscle. Aging Cell, 2014. 13(1): p. 39–48.

31 31. Fabbri, E., et al., Insulin resistance is associated with reduced mitochondrial oxidative capacity measured by 31P‐magnetic resonance spectroscopy in participants without diabetes from the Baltimore longitudinal study of aging. Diabetes, 2017. 66(1): p. 170–176.

32 32. Standley, R.A., et al., Skeletal muscle energetics and mitochondrial function are impaired following 10 days of bed rest in older adults. The Journals of Gerontology: Series A, 2020. 75(9): p. 1744–1753.

33 33. Ubaida‐Mohien, C., et al., Physical activity associated proteomics of skeletal muscle: being physically active in daily life may protect skeletal muscle from aging. Frontiers in Physiology, 2019. 10: p. 312.

34 34. Rowe, G.C., A. Safdar, and Z. Arany, Running forward: new frontiers in endurance exercise biology. Circulation, 2014. 129(7): p. 798–810.

35 35. Stessman, J., et al., Physical activity, function, and longevity among the very old. Archives of Internal Medicine, 2009. 169(16): p. 1476–1483.

36 36. Beckwée, D., et al., Exercise interventions for the prevention and treatment of sarcopenia. A systematic umbrella review. The Journal of Nutrition, Health & Aging, 2019. 23(6): p. 494–502.

37 37. Handschin, C. and B.M. Spiegelman, The role of exercise and PGC1α in inflammation and chronic disease. Nature, 2008. 454(7203): p. 463–469.

38 38. Bishop, D.J., et al., High‐intensity exercise and mitochondrial biogenesis: current controversies and future research directions. Physiology, 2019. 34(1): p. 56–70.

39 39. Hood, D.A., et al., Unravelling the mechanisms regulating muscle mitochondrial biogenesis. Biochemical Journal, 2016. 473(15): p. 2295–2314.

40 40. Sandri, M., et al., PGC‐1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy‐specific gene transcription. Proceedings of the National Academy of Sciences, 2006. 103(44): p. 16260–16265.

41 41. Eisele, P.S., et al., The peroxisome proliferator‐activated receptor γ coactivator 1α/β (PGC‐1) coactivators repress the transcriptional activity of NF‐κB in skeletal muscle cells. Journal of Biological Chemistry, 2013. 288(4): p. 2246–2260.

42 42. Garcia, S., et al., Overexpression of PGC‐1α in aging muscle enhances a subset of young‐like molecular patterns. Aging Cell, 2018. 17(2): p. e12707.

43 43. Redza‐Dutordoir, M. and D.A. Averill‐Bates, Activation of apoptosis signalling pathways by reactive oxygen species. Biochimica et Biophysica Acta (BBA)‐Molecular Cell Research, 2016. 1863(12): p. 2977–2992.

44 44. Golden, T.R., D.A. Hinerfeld, and S. Melov, Oxidative stress and aging: beyond correlation. Aging Cell, 2002. 1(2): p. 117–123.

45 45. Schlame, M., L. Horvath, and L. Vigh, Relationship between lipid saturation and lipid‐protein interaction in liver mitochondria modified by catalytic hydrogenation with reference to cardiolipin molecular species. Biochemical Journal, 1990. 265(1): p. 79–85.

46 46. Semba, R.D., et al., Tetra‐linoleoyl cardiolipin depletion plays a major role in the pathogenesis of sarcopenia. Medical Hypotheses, 2019. 127: p. 142–149.

47 47. Gonzalez‐Freire, M., et al., Targeted metabolomics shows low plasma lysophosphatidylcholine 18: 2 predicts greater decline of gait speed in older adults: the Baltimore longitudinal study of aging. The Journals of Gerontology: Series A, 2019. 74(1): p. 62–67.

48 48. Paradies, G., et al., Functional role of cardiolipin in mitochondrial bioenergetics. Biochimica et Biophysica Acta (BBA)‐Bioenergetics, 2014. 1837(4): p. 408–417.

49 49. Frohman, M.A., Role of mitochondrial lipids in guiding fission and fusion. Journal of Molecular Medicine, 2015. 93(3): p. 263–269.

50 50. Moaddel, R., et al., Plasma biomarkers of poor muscle quality in older men and women from the Baltimore Longitudinal Study of Aging. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 2016. 71(10): p. 1266–1272.

51 51. Kitajima, Y., et al., Supplementation with branched‐chain amino acids ameliorates hypoalbuminemia, prevents sarcopenia, and reduces fat accumulation in the skeletal muscles of patients with liver cirrhosis. Journal of Gastroenterology, 2018. 53(3): p. 427–437.

52 52. Beasley, J.M., J.M. Shikany, and C.A. Thomson, The role of dietary protein intake in the prevention of sarcopenia of aging. Nutrition in Clinical Practice, 2013. 28(6): p. 684–690.

53 53. Jackman, S.R., et al., Branched‐chain amino acid ingestion stimulates muscle myofibrillar protein synthesis following resistance exercise in humans. Frontiers in Physiology, 2017. 8: p. 390.

54 54. Brosnan, J.T. and M.E. Brosnan, Branched‐chain amino acids: enzyme and substrate regulation. The Journal of Nutrition, 2006. 136(1): p. 207S–211S.

55 55. Stewart, J.B. and P.F. Chinnery, The dynamics of mitochondrial DNA heteroplasmy: implications for human health and disease. Nature Reviews Genetics, 2015. 16(9): p. 530–542.

56 56. Itsara, L.S., et al., Oxidative stress is not a major contributor to somatic mitochondrial DNA mutations. PLoS Genetics, 2014. 10(2): e1003974. doi:10.1371/journal.pgen.1003974. eCollection 2014 Feb.

57 57. Smigrodzki, R.M. and S.M. Khan, Mitochondrial microheteroplasmy and a theory of aging and age‐related disease. Rejuvenation Research, 2005. 8(3): p. 172–198.

58 58. Linnane, A., et al., Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. The Lancet, 1989. 333(8639): p. 642–645.

59 59. Khrapko, K. and J. Vijg, Mitochondrial DNA mutations and aging: devils in the details? Trends in Genetics, 2009. 25(2): p. 91–98.

60 60. Trifunovic, A., et al., Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature, 2004. 429(6990): p. 417–423.

61 61. Milholland, B., Y. Suh, and J. Vijg, Mutation and catastrophe in the aging genome. Experimental Gerontology, 2017. 94: p. 34–40.

62 62. Zhang, L. and J. Vijg, Somatic mutagenesis in mammals and its implications for human disease and aging. Annual Review of Genetics, 2018. 52: p. 397–419.

63 63. Fakouri, N.B., et al., Toward understanding genomic instability, mitochondrial dysfunction and aging. The FEBS Journal, 2019. 286(6): p. 1058–1073.

64 64. Niemann, B., et al., Age and obesity‐associated changes in the expression and activation of components of the AMPK signaling pathway in human right atrial tissue. Experimental Gerontology, 2013. 48(1): p. 55–63.

65 65. Roldan, M., et al., Aerobic and resistance exercise training reverses age‐dependent decline in NAD+ salvage capacity in human skeletal muscle. Physiological Reports, 2019. 7(12): e14139. doi:10.14814/phy2.14139.

66 66. Iqbal, S., et al., Expression of mitochondrial fission and fusion regulatory proteins in skeletal muscle during chronic use and disuse. Muscle & Nerve, 2013. 48(6): p. 963–970.

67 67. Fernando, R., et al., Impaired proteostasis during skeletal muscle aging. Free Radical Biology and Medicine, 2019. 132: p. 58–66.

68 68. Chen, H., et al., Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations. Cell, 2010. 141(2): p. 280–289.

69 69. Klionsky, D.J., et al., Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy, 2016. 12(1): p. 1–222.

70 70. Sebastián, D., M. Palacín, and A. Zorzano, Mitochondrial dynamics: coupling mitochondrial fitness with healthy aging. Trends in Molecular Medicine, 2017. 23(3): p. 201–215.

71 71. Romanello, V., et al., Inhibition of the fission machinery mitigates OPA1 impairment in adult skeletal muscles. Cell, 2019. 8(6): p. 597.

72 72. Crane, J.D., et al., The effect of aging on human skeletal muscle mitochondrial and intramyocellular lipid ultrastructure. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 2010. 65(2): p. 119–128.

73 73. Sebastián, D., et al., Mfn2 deficiency links age‐related sarcopenia and impaired autophagy to activation of an adaptive mitophagy pathway. The EMBO Journal, 2016. 35(15): p. 1677–1693.

74 74. Marzetti, E., et al., Association between myocyte quality control signaling and sarcopenia in old hip‐fractured patients: results from the Sarcopenia in HIp FracTure (SHIFT) exploratory study. Experimental Gerontology, 2016. 80: p. 1–5.

75 75. Ferrucci, L. and E. Fabbri, Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nature Reviews Cardiology, 2018. 15(9): p. 505–522.

76 76. Nakahira, K., et al., Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nature Immunology, 2011. 12(3): p. 222.

77 77. West, A.P., et al., Mitochondrial DNA stress primes the antiviral innate immune response. Nature, 2015. 520(7548): p. 553–557.

78 78. Franceschi, C. and J. Campisi, Chronic inflammation (inflammaging) and its potential contribution to age‐associated diseases. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 2014. 69(Suppl_1): p. S4–S9.

79 79. Bano, G., et al., Inflammation and sarcopenia: a systematic review and meta‐analysis. Maturitas, 2017. 96: p. 10–15.

80 80. Marzetti, E., et al., Mitochondrial death effectors: relevance to sarcopenia and disuse muscle atrophy. Biochimica et Biophysica Acta (BBA) ‐ General Subjects, 2010. 1800(3): p. 235–244.

81 81. Dirks, A.J. and C. Leeuwenburgh, The role of apoptosis in age‐related skeletal muscle atrophy. Sports Medicine, 2005. 35(6): p. 473–483.

82 82. Dirks, A. and C. Leeuwenburgh, Apoptosis in skeletal muscle with aging. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, 2002. 282(2): p. R519–R527.

83 83. Edström, E., et al., Atrogin‐1/MAFbx and MuRF1 are downregulated in aging‐related loss of skeletal muscle. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 2006. 61(7): p. 663–674.

84 84. Martinez‐Redondo, V., et al., Peroxisome proliferator‐activated receptor γ coactivator‐1 α isoforms selectively regulate multiple splicing events on target genes. Journal of Biological Chemistry, 2016. 291(29): p. 15169–15184.

85 85. Rattray, N.J., et al., Metabolic dysregulation in vitamin. E and carnitine shuttle energy mechanisms associate with human frailty Nature Communications, 2019. 10(1): p. 1–12.